Drug General Information (ID: DDI9EMLY8U)
  Drug Name Interferon gamma-1b Drug Info Palifermin Drug Info
  Drug Type Interferons Protein/peptide
  Therapeutic Class Immunomodulatory Agents Antimucositis Agents

 Mechanism of Interferon gamma-1b-Palifermin Interaction (Severity Level: Moderate)
     Additive immunosuppressive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Interferon gamma-1b Palifermin
      Mechanism Immunosuppressive effects Immunomodulatory effects (fibroblast growth factor)
      Key Mechanism Factor 1
Factor Name Immunosuppressive effects
Factor Description Immunosuppression is when your immune system is not functioning as it should. The immune system is made up of cells, tissues and organs that help the body fight off infections. If the immune system is suppressed, an infection that your body was able to control may become serious or even fatal.
      Mechanism Description
  • Additive immunosuppressive effects by the combination of Palifermin and Interferon gamma-1b 

Recommended Action
      Management Palifermin should not be administered within 24 hours before, during infusion of, or within 24 hours after administration of myelotoxic chemotherapy.

References
1 Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.